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Gastrointestinal bleeding following NSAID ingestion
in children
Lofty-John C. Anyanwu and Aminu M. Mohammad
Gastrointestinal (GI) bleeding could result from various
conditions in a child, and could be life threatening.
Severe GI bleeds are, however, rare and their incidence is
relatively unknown. Here, we report on two children who
presented with GI bleeding following ingestion of NSAID.
Two female children presented to our unit with GI bleeding.
One was 6 years old and the other was 2 years old.
Both presented with a history of fever and passage of
bloody stools. There was a positive history of NSAID
ingestion in both patients that was prescribed in the
referring hospitals. The older child had a packed cell
volume of 19% on presentation, and digital rectal
examination indicated melaena. There was no history of
vomiting. She received one unit of blood transfusion and
was managed nonoperatively with antacids. Her recovery
was uneventful. The younger patient presented with an
abdominal distension and peritonitis, packed cell volume
was 17% on presentation, and was malnourished.
Exploratory laparatomy showed two kissing perforations,
one measuring about 2 cm in the second part of the
duodenum and the other measuring 1 cm in the
gallbladder. There were no demonstrable gallstones.
She underwent a cholecystectomy and closure of the
duodenal perforation. The patient, however, developed a
superficial surgical site infection that responded
to local wound care. Recovery was otherwise uneventful.
A thorough assessment of drug history should be
performed to rule out NSAID ingestion in a child with a GI
bleed. Ann Pediatr Surg 9:87–89 c 2013 Annals of
Pediatric Surgery.
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Introduction
Gastrointestinal (GI) bleeding resulting from various
causes is common in children [1]. Severe life-threatening
ones are, however, rare, and their incidence is relatively
unknown.
NSAIDs are commonly used as antipyretic, analgesic, and
anti-inflammatory agents. They are also used in cancer,
Alzheimer’s disease, and cardiovascular diseases [2].
These drugs are known to cause injury throughout the
GI tract [1].
Elderly patients account for a large proportion of chronic
users of NSAIDs [2]. The risk and the magnitude of
NSAID-induced GI injury in children are uncertain.




A 6-year-old girl presented to our unit with a 1-week
history of fever and passage of bloody stools for about
48 h before presentation. She had earlier been seen in a
peripheral hospital, and was administered some medica-
tions that included Ibuprofen syrup. The patient had
been on Ibuprofen for about 5 days before presentation,
although the dosage administered could not be deter-
mined from the mother. She had no history of a similar
bleeding.
Examination on presentation indicated a severely ill-
looking child who was febrile (temperature 381C),
dehydrated, and pale. There were no peripheral stigmata
of chronic liver disease. She was lethargic but conscious.
Her packed cell volume (PCV) was 19% (PCV <30%
defined as anemia for the age group by our laboratory).
Coagulation studies were not performed. A digital rectal
examination showed melaena. There were no signs of
peritonitis. The patient received an initial fluid resuscita-
tion, followed by blood transfusion. An empirical anti-
malarial therapy was instituted on account of the pyrexia
and oral antacids were administered. Her recovery was
uneventful and she was discharged after 1 week of
admission.
Case 2
A 2-year-old girl presented to us with a 10-day history of
fever and a 2-day history of passage of bloody stools, with
a progressive abdominal distension. She was initially seen
in a peripheral hospital and was administered some
medication that included Ibuprofen syrup. She was on
the medication for about 1 week before presentation to
our hospital. The dosage of the Ibuprofen could not be
ascertained from her mother. She had no history of an
abnormal bleed. Examination at presentation indicated a
severely ill-looking child who was febrile (temperature
38.51C), pale, and anicteric. Her PCV was 17% (PCV
<30% defined as anemia for the age group by our
laboratory). Coagulation studies were not performed. She
was malnourished, with bilateral pitting pedal edema.
Her abdomen was distended, and not moving with
respiration, with a generalized tenderness. The examin-
ing finger was stained with blood following a digital rectal
examination. An erect abdominal radiograph that in-
cluded the lower chest showed air under the right hemi
diaphragm. She underwent an emergency laparatomy
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following resuscitation and blood transfusion. The find-
ings at surgery were two kissing perforations, one
measuring about 2 cm in diameter in the second part of
the duodenum and the other measuring 1 cm in diameter
in the gallbladder (Fig. 1). There were no demonstrable
gallstones. The duodenal perforation was closed and she
underwent a cholecystectomy. The patient received a
course of postoperative antibiotics and antacids. She,
however, developed a surgical site infection that
responded to local care. Nutritional rehabilitation was
instituted, and following an improved clinical condition,
she was discharged home after 40 days of admission.
Discussion
GI injury is a major adverse effect of NSAID use. The
use of these drugs is known to disrupt GI-protective
mechanisms, which include mucosal blood flow and
mucus secretion [3]. These disruptions lead to an
impairment in the ability of the mucosa to respond to
or to resist injury. The suppression of mucosal prosta-
glandin synthesis, by the systemic inhibition of cyclooxy-
genase (COX) enzymes, confers on NSAIDs their ability
to injure the GI mucosa [2–4]. NSAIDs, being weak
acids, also cause topical mucosal irritation and damage by
various mechanisms [2].
It is estimated that in the USA, about 100 000
hospitalizations occur each year for serious NSAID-
associated GI complications, with an annual mortality of
about 16 500 patients [5].
There is a paucity of data on the incidence of these
injuries in the pediatric population. In our environment,
NSAID syrups are readily available over the counter drugs
that some use as antipyretic or analgesic agents. Both of
our patients had taken Ibuprofen syrup prescribed in
peripheral hospitals before the onset of their GI bleeding.
Different NSAIDs do show different risks for GI
ulceration [4]. Studies in Denmark have shown that for
Ibuprofen and Naproxen, there was a clear trend in an
increasing risk for upper GI bleeding with increasing
dose [6].
It is believed that NSAID-induced enteropathy is more
common than injuries of the stomach and duodenum,
manifesting usually as occult blood loss or hypoalbumine-
mia [5,7]. The mechanisms responsible for NSAID-
induced enteropathy have not been fully understood [4,5].
Topical irritation by NSAIDs appear to play a role here,
given that enterohepatic recirculation of these drugs
prolongs the exposure of the intestinal mucosa to them,
with the luminal bile and enterobacteria potentiating the
damage after the initial increase in gut permeability
induced by the NSAID [3,4]. Parenterally administered
NSAIDs could also lead to intestinal mucosal injury, as it
has been shown in experiments in rats that subcutaneously
administered indomethacin caused jejunal and ileal
mucosal damages [3]. Systemic inhibition of COX-1 and
COX-2 enzymes may be involved [5].
Systemic inhibition of COX-1 is believed to lead to the
release of endothelin-1 a potent vasoconstrictor, which
may induce mucosal injury by the reduction of blood
flow [8]. Sustained vasoconstriction worsens mucosal
injuries, causing extensive necrosis and hemorrhage [4,8].
In the adult population, the risk of progression of
NSAID-induced ulcers to the development of bowel
perforation or excessive hemorrhage in chronic NSAID
users is 2–4% [4].
It has been shown in animal experiments that there is an
age-dependent variation in intestinal injury [9,10]. Both
of our patients were children who developed GI bleeding
following NSAID use.
Nitric oxide (NO), a vasodilator, is believed to mediate
certain physiological functions in the GI tract that
include mucosal blood flow, maintenance of mucosal
integrity, and maintenance of vascular tone [3]. The
inducible NO synthase (iNOS), one of the three isoforms
of NO synthase, is characterized by its ability to produce
high quantities of NO [9]. It has been shown that iNOS
activation in response to lipopolysaccharide stimulation in
the ileum of rats varies with age, being 10-fold higher in
adolescents than in neonates [3,9]. Gosche et al. [10]
reported that in rats, the neonatal intestine had a reduced
compensatory response to hemorrhage, hypothermia, and
hypoxia compared with the adult’s. Some believe that
reduced iNOS induction may explain why the intestinal
microvasculature in the immature rats lacks vasodilator
responses that are active in the mature rats [9].
Studies have shown that most GI injuries following
NSAID use would commonly occur within the first 30
days following the commencement of the NSAID [11].
Both of our patients had been on Ibuprofen for about
1 week before the onset of bloody stools.
Fig. 1
Intraoperative image showing gallbladder perforation (artery forceps as
a pointer). Opposite is duodenal perforation.
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Our second patient presented with a duodenal perforation
together with a gallbladder perforation (Fig. 1). We were
unable to ascertain whether one was related to the other or
whether they were both independent injuries resulting from
NSAID use. We are not aware of any report in the literature
of a gallbladder perforation induced by NSAID use. This
report of a gallbladder perforation following NSAID use may
be an unexplored topic for NSAID-associated injury, given
the role of enterohepatic circulation in concentrating these
drugs in the biliary system [4,5]. Endoscopic studies could
not be performed in these patients because of the non
availability of this facility in our institution.
NSAID enteropathy may produce a higher disease burden
in children, given that there are age-related differences
in the effectiveness of intestinal blood flow autoregula-
tion [10]. The mucosal epithelium is believed to be the
primary barrier against bacterial translocation in the
intestine, [9] and injuries to this barrier will allow gut
bacterial translocation, leading to septicemia, and may
also manifest as NSAID enteropathy, resulting in occult
blood loss and hypoalbuminemia [7].
The prolonged duration of admission (40 days) in our
second patient was because of the long period of
nutritional rehabilitation she had to undergo. This long
duration of admission constituted an enormous financial
burden to her parents. Her malnourished state also
contributed toward her poor wound outcome.
We recommend that a high index of suspicion should be
adopted in the evaluation and management of any child
with a GI bleed, and that a thorough assessment of drug
history should be carried out to rule out NSAID ingestion.
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